Global Wound Biologics Market Research Report 2021

1 Wound Biologics Market Overview

• 1.1 Product Overview and Scope of Wound Biologics
• 1.2 Wound Biologics Segment by Type
  • 1.2.1 Global Wound Biologics Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Biological Skin Substitutes
  • 1.2.3 Enzyme Preparation
  • 1.2.4 Growth Factor
• 1.3 Wound Biologics Segment by Application
  • 1.3.1 Wound Biologics Sales Comparison by Application: (2021-2027)
  • 1.3.2 Hospital
  • 1.3.3 Drugstore
  • 1.3.4 Others
• 1.4 Global Wound Biologics Market Size Estimates and Forecasts
  • 1.4.1 Global Wound Biologics Revenue 2016-2027
  • 1.4.2 Global Wound Biologics Sales 2016-2027
  • 1.4.3 Wound Biologics Market Size by Region: 2016 Versus 2021 Versus 2027

2 Wound Biologics Market Competition by Manufacturers

• 2.1 Global Wound Biologics Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Wound Biologics Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Wound Biologics Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Wound Biologics Manufacturing Sites, Area Served, Product Type
• 2.5 Wound Biologics Market Competitive Situation and Trends
  • 2.5.1 Wound Biologics Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Wound Biologics Players Market Share by Revenue
  • 2.5.3 Global Wound Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Wound Biologics Retrospective Market Scenario by Region

• 3.1 Global Wound Biologics Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Wound Biologics Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Wound Biologics Market Facts & Figures by Country
  • 3.3.1 North America Wound Biologics Sales by Country
  • 3.3.2 North America Wound Biologics Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Wound Biologics Market Facts & Figures by Country
  • 3.4.1 Europe Wound Biologics Sales by Country
  • 3.4.2 Europe Wound Biologics Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Wound Biologics Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Wound Biologics Sales by Region
  • 3.5.2 Asia Pacific Wound Biologics Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Wound Biologics Market Facts & Figures by Country
  • 3.6.1 Latin America Wound Biologics Sales by Country
  • 3.6.2 Latin America Wound Biologics Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Wound Biologics Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Wound Biologics Sales by Country
  • 3.7.2 Middle East and Africa Wound Biologics Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 U.A.E

4 Global Wound Biologics Historic Market Analysis by Type

• 4.1 Global Wound Biologics Sales Market Share by Type (2016-2021)
• 4.2 Global Wound Biologics Revenue Market Share by Type (2016-2021)
• 4.3 Global Wound Biologics Price by Type (2016-2021)

5 Global Wound Biologics Historic Market Analysis by Application

• 5.1 Global Wound Biologics Sales Market Share by Application (2016-2021)
• 5.2 Global Wound Biologics Revenue Market Share by Application (2016-2021)
• 5.3 Global Wound Biologics Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Avita Medical
  • 6.1.1 Avita Medical Corporation Information
  • 6.1.2 Avita Medical Description and Business Overview
  • 6.1.3 Avita Medical Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Avita Medical Product Portfolio
  • 6.1.5 Avita Medical Recent Developments/Updates
• 6.2 ConvaTec
  • 6.2.1 ConvaTec Corporation Information
  • 6.2.2 ConvaTec Description and Business Overview
  • 6.2.3 ConvaTec Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 ConvaTec Product Portfolio
  • 6.2.5 ConvaTec Recent Developments/Updates
• 6.3 Acelity
  • 6.3.1 Acelity Corporation Information
  • 6.3.2 Acelity Description and Business Overview
  • 6.3.3 Acelity Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Acelity Product Portfolio
  • 6.3.5 Acelity Recent Developments/Updates
• 6.4 Cytori Therapeutic
  • 6.4.1 Cytori Therapeutic Corporation Information
  • 6.4.2 Cytori Therapeutic Description and Business Overview
  • 6.4.3 Cytori Therapeutic Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Cytori Therapeutic Product Portfolio
  • 6.4.5 Cytori Therapeutic Recent Developments/Updates
• 6.5 MacroCure
  • 6.5.1 MacroCure Corporation Information
  • 6.5.2 MacroCure Description and Business Overview
  • 6.5.3 MacroCure Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 MacroCure Product Portfolio
  • 6.5.5 MacroCure Recent Developments/Updates
• 6.6 Nuo Therapeutics
  • 6.6.1 Nuo Therapeutics Corporation Information
  • 6.6.2 Nuo Therapeutics Description and Business Overview
  • 6.6.3 Nuo Therapeutics Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Nuo Therapeutics Product Portfolio
  • 6.6.5 Nuo Therapeutics Recent Developments/Updates
• 6.7 Molyncke Health Care
  • 6.6.1 Molyncke Health Care Corporation Information
  • 6.6.2 Molyncke Health Care Description and Business Overview
  • 6.6.3 Molyncke Health Care Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Molyncke Health Care Product Portfolio
  • 6.7.5 Molyncke Health Care Recent Developments/Updates
• 6.8 Osiris Therapeutics
  • 6.8.1 Osiris Therapeutics Corporation Information
  • 6.8.2 Osiris Therapeutics Description and Business Overview
  • 6.8.3 Osiris Therapeutics Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Osiris Therapeutics Product Portfolio
  • 6.8.5 Osiris Therapeutics Recent Developments/Updates
• 6.9 Smith And Nephew
  • 6.9.1 Smith And Nephew Corporation Information
  • 6.9.2 Smith And Nephew Description and Business Overview
  • 6.9.3 Smith And Nephew Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Smith And Nephew Product Portfolio
  • 6.9.5 Smith And Nephew Recent Developments/Updates
• 6.10 Organogenesis
  • 6.10.1 Organogenesis Corporation Information
  • 6.10.2 Organogenesis Description and Business Overview
  • 6.10.3 Organogenesis Wound Biologics Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Organogenesis Product Portfolio
  • 6.10.5 Organogenesis Recent Developments/Updates

7 Wound Biologics Manufacturing Cost Analysis

• 7.1 Wound Biologics Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Wound Biologics
• 7.4 Wound Biologics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Wound Biologics Distributors List
• 8.3 Wound Biologics Customers

9 Wound Biologics Market Dynamics

• 9.1 Wound Biologics Industry Trends
• 9.2 Wound Biologics Growth Drivers
• 9.3 Wound Biologics Market Challenges
• 9.4 Wound Biologics Market Restraints

10 Global Market Forecast

• 10.1 Wound Biologics Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Wound Biologics by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Wound Biologics by Type (2022-2027)
• 10.2 Wound Biologics Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Wound Biologics by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Wound Biologics by Application (2022-2027)
• 10.3 Wound Biologics Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Wound Biologics by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Wound Biologics by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List